Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

EXPLAINED: 7 - The Real Truth

Aurora Cannabis Is Selling Stock To Pay Off Debt: Why Tilray And Canopy Could Be Next In Line

Earlier this month, Aurora Cannabis (NASDAQ: ABC) reported its second-quarter financial results, revealing a 10% decline in total net revenue, which totaled slig

Benzinga · Feb 28, 2022

Where Will Tilray's Stock Be In 2025? Survey Says...

Tilray Inc (NASDAQ: TLRY), a Canadian pharmaceutical and cannabis company, is one of the most popular cannabis stocks out there. Back in 2018, the stock ran all the way to $148 before coming back down to the single digits.

Benzinga · Feb 25, 2022

Cannabis Movers & Shakers: MedMen, Organigram, NeonMind, Green Check Verified

Former Tilray Exec Ana Bowman Joins MedMen As CFO MedMen Enterprises Inc. (CSE: MMEN) (OTCQX: MMNFF) has appointed Ana Bowman as a chief financial officer, effective February 22.

Benzinga · Feb 24, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

Tilray Launches Medical Cannabis Products In Malta

Tilray Brands, Inc.

Benzinga · Feb 17, 2022

Weed'n Whiskey: Why Tilray Thinks There Is Gold In Cannabis-Infused Whiskey

This article was originally published on Cannabis.net and appears here with permission.

Benzinga · Feb 14, 2022

The Week In Cannabis: Schumer's Bill, The Super Bowl, Leafly, Canopy Growth, Tilray, Hexo, Sundial And More

Below is a recap of the main news related to the cannabis industry and markets for the week of February 7, 2022. Contents

Benzinga · Feb 11, 2022

Tilray Stock Is Having A Green Day: What's Going On?

Tilray Inc.

Benzinga · Feb 9, 2022

Read news from The Economist, FT, and more,
with one subscription

Tilray Consolidates Its Portfolio Of Brands & Products Into Tilray Medical

Tilray Brands, Inc. (NASDAQ: TLRY) (TSX:TLRY) announced the launch of Tilray Medical, a global medical platform

Benzinga · Feb 8, 2022

Chart Wars: Between Tilray And Canopy Growth, Which Cannabis Stock Could Slam Shorts Harder?

Canopy Growth Corporation (NASDAQ: CGC) and Tilray, Inc (NASDAQ: TLRY) soared 10.59% and 8.76%, respectively, on Monday.

Benzinga · Feb 1, 2022

Tilray Expands Medical Marijuana Product Offering In Australia, Launches Cannabis E-Learning Platform

Marijuana giant Tilray Brands, Inc. (NASDAQ: TLRY) (TSX: TLRY) announced on Tuesday the expansion of its medical cannabis product offering in Australia and the launch of a new medical cannabis e-learning platform for healthcare providers.

Benzinga · Jan 25, 2022

EXCLUSIVE: Why One Top Hedge Fund Manager Is Bullish On US Cannabis Stocks

Investment expert and former hedge fund manager Whitney Tilson, current president and CEO of Empire Financial Research, recently stopped by Benzinga Cannabis Hour to discuss his investment thesis including his 2022 outlook as it pertains to the

Benzinga · Jan 18, 2022

Best Marijuana Stocks to Buy: Cannabis Stocks for Investing

The best marijuana stocks have been put through the wringer for years. But with U.S. cannabis sales on the rise, these picks could finally have their day in the sun.

Kiplinger · Nov 2, 2020

1 … 4 5 6 7

Coverage From

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Canopy Growth Corporation

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.